Fulvestrant plus capivasertib versus placebo in metastatic ER positive breast cancer (FAKTION): a randomised, double-blind, placebo-controlled, phase II trial
BREAST CANCER RESEARCH AND TREATMENT(2020)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要